130 related articles for article (PubMed ID: 28807768)
1. European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation.
Zhu X; Huang L; Zheng C; Tang B; Liu H; Geng L; Tong J; Zhang L; Zhang X; Yao W; Song K; Wang X; Ding K; Sun Z
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2118-2126. PubMed ID: 28807768
[TBL] [Abstract][Full Text] [Related]
2. EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation.
Wang HT; Chang YJ; Xu LP; Liu DH; Wang Y; Liu KY; Huang XJ
Bone Marrow Transplant; 2014 Jul; 49(7):927-33. PubMed ID: 24777191
[TBL] [Abstract][Full Text] [Related]
3. Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine.
Giannotti F; Labopin M; Shouval R; Sanz J; Arcese W; Angelucci E; Sierra J; Santasusana JR; Santarone S; Benedetto B; Rambaldi A; Saccardi R; Blaise D; Carella MA; Rocha V; Baron F; Mohty M; Ruggeri A; Nagler A
J Hematol Oncol; 2018 Aug; 11(1):110. PubMed ID: 30165887
[TBL] [Abstract][Full Text] [Related]
4. Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.
Shouval R; Bonifazi F; Fein J; Boschini C; Oldani E; Labopin M; Raimondi R; Sacchi N; Dabash O; Unger R; Mohty M; Rambaldi A; Nagler A
Am J Hematol; 2017 May; 92(5):429-434. PubMed ID: 28181279
[TBL] [Abstract][Full Text] [Related]
5. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation.
Baron F; Labopin M; Ruggeri A; Mohty M; Sanz G; Milpied N; Bacigalupo A; Rambaldi A; Bonifazi F; Bosi A; Sierra J; Yakoub-Agha I; Santasusana JM; Gluckman E; Nagler A
J Hematol Oncol; 2015 Oct; 8():107. PubMed ID: 26445106
[TBL] [Abstract][Full Text] [Related]
6. Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.
Mallhi KK; Smith AR; DeFor TE; Lund TC; Orchard PJ; Miller WP
Biol Blood Marrow Transplant; 2017 Jan; 23(1):119-125. PubMed ID: 27989932
[TBL] [Abstract][Full Text] [Related]
7. A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants.
Hemmati PG; Terwey TH; le Coutre P; Vuong LG; Massenkeil G; Dörken B; Arnold R
Eur J Haematol; 2011 Apr; 86(4):305-16. PubMed ID: 21265883
[TBL] [Abstract][Full Text] [Related]
8. Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantation.
Chang YJ; Wang HT; Xu LP; Wang Y; Liu KY; Zhang XH; Liu DH; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Yan CH; Tang FF; Mo XD; Huang XJ
Leuk Lymphoma; 2016 Sep; 57(9):2133-9. PubMed ID: 26857549
[TBL] [Abstract][Full Text] [Related]
9. Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.
Lodewyck T; Oudshoorn M; van der Holt B; Petersen E; Spierings E; von dem Borne PA; Schattenberg A; Allebes W; Groenendijk-Sijnke M; Duinhouwer L; Willemze R; Lowenberg B; Verdonck LF; Meijer E; Cornelissen JJ
Leukemia; 2011 Oct; 25(10):1548-54. PubMed ID: 21606965
[TBL] [Abstract][Full Text] [Related]
10. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
Barba P; Martino R; Pérez-Simón JA; Fernández-Avilés F; Castillo N; Piñana JL; López-Anglada L; Rovira M; Bosch F; Carreras E; Corral LL; Sierra J; Valcárcel D
Biol Blood Marrow Transplant; 2014 Jan; 20(1):66-72. PubMed ID: 24141006
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Aladağ E; Demiroğlu H; Büyükaşık Y; Göker H
Turk J Haematol; 2021 Jun; 38(2):138-144. PubMed ID: 32539316
[TBL] [Abstract][Full Text] [Related]
12. Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI Score.
Michelis FV; Messner HA; Uhm J; Alam N; Lambie A; McGillis L; Seftel MD; Gupta V; Kuruvilla J; Lipton JH; Kim DD
Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):e73-81. PubMed ID: 25458081
[TBL] [Abstract][Full Text] [Related]
13. [Results of unrelated umbilical cord blood stem cell transplantation for 65 patients in China].
Liao C; Yang X; Xu ZP; Huang YN; Wu SQ; Chen JS; Li Y; Tang XW; Wu JY
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):220-3. PubMed ID: 16624064
[TBL] [Abstract][Full Text] [Related]
14. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT.
van Gelder M; Ziagkos D; de Wreede L; van Biezen A; Dreger P; Gramatzki M; Stelljes M; Andersen NS; Schaap N; Vitek A; Beelen D; Lindström V; Finke J; Passweg J; Eder M; Machaczka M; Delgado J; Krüger W; Raida L; Socié G; Jindra P; Afanasyev B; Wagner E; Chalandon Y; Henseler A; Schoenland S; Kröger N; Schetelig J;
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):667-675.e2. PubMed ID: 28694085
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of EBMT score for chronic myeloid leukemia patients in allogeneic stem cell transplantation].
Hu J; Zhang WP; Yang D; Tang W; Song XM; Wang L; Zhao WL; Wu W; Wang JM
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):75-8. PubMed ID: 21429370
[TBL] [Abstract][Full Text] [Related]
16. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
[TBL] [Abstract][Full Text] [Related]
17. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
Sanz J; Jaramillo FJ; Planelles D; Montesinos P; Lorenzo I; Moscardó F; Martin G; López F; Martínez J; Jarque I; de la Rubia J; Larrea L; Sanz MA; Sanz GF
Biol Blood Marrow Transplant; 2014 Jan; 20(1):106-10. PubMed ID: 24516896
[TBL] [Abstract][Full Text] [Related]
18. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ;
N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544
[TBL] [Abstract][Full Text] [Related]
19. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation.
Iori AP; Cerretti R; De Felice L; Screnci M; Mengarelli A; Romano A; Caniglia M; Cerilli L; Gentile G; Moleti ML; Giona F; Agostini F; Pasqua I; Perrone MP; Pinto MR; Grapulin L; Testi AM; Martino P; De Rossi G; Mandelli F; Arcese W
Bone Marrow Transplant; 2004 Jun; 33(11):1097-105. PubMed ID: 15094744
[TBL] [Abstract][Full Text] [Related]
20. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V
Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
